This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sia, I. G.
Right arrow Articles by Patel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sia, I. G.
Right arrow Articles by Patel, R.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, January 2000, p. 83-121, Vol. 13, No. 1
0893-8512/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients

Irene G. Sia and Robin Patel*

Division of Infectious Diseases and Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905

In the past three decades since the inception of human organ transplantation, cytomegalovirus (CMV) has gained increasing clinical import because it is a common pathogen in the immunocompromised transplant recipient. Patients may suffer from severe manifestations of this infection along with the threat of potential fatality. Additionally, the dynamic evolution of immunosuppressive and antiviral agents has brought forth changes in the natural history of CMV infection and disease. Transplant physicians now face the daunting task of recognizing and managing the changing spectrum of CMV infection and its consequences in the organ recipient. For the microbiology laboratory, the emphasis has been geared toward the development of more sophisticated detection assays, including methods to detect emerging antiviral resistance. The discovery of novel antiviral chemotherapy is an important theme of clinical research. Investigations have also focused on preventative measures for CMV disease in the solid-organ transplant population. In all, while much has been achieved in the overall management of CMV infection, the current understanding of CMV pathogenesis and therapy still leaves much to be learned before success can be claimed.

* Corresponding author. Mailing address: Division of Infectious Diseases and Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905. Phone: (507) 255-7762. Fax: (507) 255-7767. E-mail: patel.robin{at}mayo.edu.

Clinical Microbiology Reviews, January 2000, p. 83-121, Vol. 13, No. 1
0893-8512/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Caliendo, A. M., Shahbazian, M. D., Schaper, C., Ingersoll, J., Abdul-Ali, D., Boonyaratanakornkit, J., Pang, X.-L., Fox, J., Preiksaitis, J., Schonbrunner, E. R. (2009). A Commutable Cytomegalovirus Calibrator Is Required to Improve the Agreement of Viral Load Values between Laboratories. Clin. Chem. 55: 1701-1710 [Abstract] [Full Text]  
  • Crough, T., Khanna, R. (2009). Immunobiology of Human Cytomegalovirus: from Bench to Bedside. Clin. Microbiol. Rev. 22: 76-98 [Abstract] [Full Text]  
  • Swan, S. K., Smith, W. B., Marbury, T. C., Schumacher, M., Dougherty, C., Mico, B. A., Villano, S. A. (2007). Pharmacokinetics of Maribavir, a Novel Oral Anticytomegalovirus Agent, in Subjects With Varying Degrees of Renal Impairment. J Clin Pharmacol 47: 209-217 [Abstract] [Full Text]  
  • van Ree, R. M., Oterdoom, L. H., de Vries, A. P. J., Gansevoort, R. T., van der Heide, J. J. H., van Son, W. J., Ploeg, R. J., de Jong, P. E., Gans, R. O. B., Bakker, S. J. L., , on behalf of the Renal Transplant Program, Unive, (2007). Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. Nephrol Dial Transplant 22: 246-253 [Abstract] [Full Text]  
  • Kalil, A. C., Levitsky, J., Lyden, E., Stoner, J., Freifeld, A. G. (2005). Meta-Analysis: The Efficacy of Strategies To Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients. ANN INTERN MED 143: 870-880 [Abstract] [Full Text]  
  • Gilbert, C., Boivin, G. (2005). New Reporter Cell Line To Evaluate the Sequential Emergence of Multiple Human Cytomegalovirus Mutations during In Vitro Drug Exposure. Antimicrob. Agents Chemother. 49: 4860-4866 [Abstract] [Full Text]  
  • Williams-Aziz, S. L., Hartline, C. B., Harden, E. A., Daily, S. L., Prichard, M. N., Kushner, N. L., Beadle, J. R., Wan, W. B., Hostetler, K. Y., Kern, E. R. (2005). Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro. Antimicrob. Agents Chemother. 49: 3724-3733 [Abstract] [Full Text]  
  • Uknis, M. E. (2005). Prophylaxis of cytomegalovirus disease in transplant patients. Am J Health Syst Pharm 62: S3-S6 [Abstract] [Full Text]  
  • Gilbert, C., Boivin, G. (2005). Human Cytomegalovirus Resistance to Antiviral Drugs. Antimicrob. Agents Chemother. 49: 873-883 [Full Text]  
  • Kishore, J., Ghoshal, U., Ghoshal, U. C, Krishnani, N., Kumar, S., Singh, M., Ayyagari, A. (2004). Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 53: 1155-1160 [Abstract] [Full Text]  
  • Stern, J., Shai, E., Zaks, B., Halabi, A., Houri-Haddad, Y., Shapira, L., Palmon, A. (2004). Reduced Expression of Gamma Interferon in Serum and Marked Lymphoid Depletion Induced by Porphyromonas gingivalis Increase Murine Morbidity and Mortality due to Cytomegalovirus Infection. Infect. Immun. 72: 5791-5798 [Abstract] [Full Text]  
  • Kotloff, R. M., Ahya, V. N., Crawford, S. W. (2004). Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation. Am. J. Respir. Crit. Care Med. 170: 22-48 [Abstract] [Full Text]  
  • Underwood, M. R., Ferris, R. G., Selleseth, D. W., Davis, M. G., Drach, J. C., Townsend, L. B., Biron, K. K., Boyd, F. L. (2004). Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human Cytomegalovirus. Antimicrob. Agents Chemother. 48: 1647-1651 [Abstract] [Full Text]  
  • Komazin, G., Ptak, R. G., Emmer, B. T., Townsend, L. B., Drach, J. C. (2003). Resistance of Human Cytomegalovirus to the Benzimidazole L-Ribonucleoside Maribavir Maps to UL27. J. Virol. 77: 11499-11506 [Abstract] [Full Text]  
  • Jenkins, F. J., Rowe, D. T., Rinaldo, C. R. Jr. (2003). Herpesvirus Infections in Organ Transplant Recipients. CVI 10: 1-7 [Full Text]  
  • Boom, R., Sol, C. J. A., Schuurman, T., van Breda, A., Weel, J. F. L., Beld, M., ten Berge, I. J. M., Wertheim-van Dillen, P. M. E, de Jong, M. D. (2002). Human Cytomegalovirus DNA in Plasma and Serum Specimens of Renal Transplant Recipients Is Highly Fragmented. J. Clin. Microbiol. 40: 4105-4113 [Abstract] [Full Text]  
  • Kaiser, L., Perrin, L., Chapuis, B., Hadaya, K., Kolarova, L., Deffernez, C., Huguet, S., Helg, C., Wunderli, W. (2002). Improved Monitoring of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation by an Ultrasensitive Plasma DNA PCR Assay. J. Clin. Microbiol. 40: 4251-4255 [Abstract] [Full Text]  
  • Biron, K. K., Harvey, R. J., Chamberlain, S. C., Good, S. S., Smith, A. A. III, Davis, M. G., Talarico, C. L., Miller, W. H., Ferris, R., Dornsife, R. E., Stanat, S. C., Drach, J. C., Townsend, L. B., Koszalka, G. W. (2002). Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole L-Riboside with a Unique Mode of Action. Antimicrob. Agents Chemother. 46: 2365-2372 [Abstract] [Full Text]  
  • Piiparinen, H., Hockerstedt, K., Lappalainen, M., Suni, J., Lautenschlager, I. (2002). Monitoring of Viral Load by Quantitative Plasma PCR during Active Cytomegalovirus Infection of Individual Liver Transplant Patients. J. Clin. Microbiol. 40: 2945-2952 [Abstract] [Full Text]  
  • Sequar, G., Britt, W. J., Lakeman, F. D., Lockridge, K. M., Tarara, R. P., Canfield, D. R., Zhou, S.-S., Gardner, M. B., Barry, P. A. (2002). Experimental Coinfection of Rhesus Macaques with Rhesus Cytomegalovirus and Simian Immunodeficiency Virus: Pathogenesis. J. Virol. 76: 7661-7671 [Abstract] [Full Text]  
  • BRENNAN, D. C. (2001). Cytomegalovirus in Renal Transplantation. J. Am. Soc. Nephrol. 12: 848-855 [Full Text]  
  • Blok, M. J., Lautenschlager, I., Goossens, V. J., Middeldorp, J. M., Vink, C., Hockerstedt, K., Bruggeman, C. A. (2000). Diagnostic Implications of Human Cytomegalovirus Immediate Early-1 and pp67 mRNA Detection in Whole-Blood Samples from Liver Transplant Patients Using Nucleic Acid Sequence-Based Amplification. J. Clin. Microbiol. 38: 4485-4491 [Abstract] [Full Text]  
  • Pas, S. D., Fries, E., De Man, R. A., Osterhaus, A. D. M. E., Niesters, H. G. M. (2000). Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays. J. Clin. Microbiol. 38: 2897-2901 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»